CAS: 104104-50-9 - Gabazine
Formula:C15H17N3O3·BrH
InChI:InChI=1S/C15H17N3O3.BrH/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20;/h4-9,16H,2-3,10H2,1H3,(H,19,20);1H
InChI key:InChIKey=GFZHNFOGCMEYTA-UHFFFAOYSA-N
SMILES:Br.O=C(O)CCCN1N=C(C=CC1=N)C=2C=CC(OC)=CC2
- Synonyms:
- 1(6H)-Pyridazinebutanoic acid, 6-imino-3-(4-methoxyphenyl)-, hydrobromide (1:1)
- 1(6H)-Pyridazinebutanoic acid, 6-imino-3-(4-methoxyphenyl)-, monohydrobromide
- Gabazine
- SR 95531
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
SR-95531 REF: IN-DA008SG4CAS: 104104-50-9 | % | To inquire | Tue 07 Jan 25 | |
Gabazine REF: TM-T7622CAS: 104104-50-9 | 98.51% | 51.00 €~612.00 € | Tue 14 Jan 25 | |
SR 95531 hydrobromide REF: 3D-BS43265CAS: 104104-50-9 | Min. 95% | 164.00 €~488.00 € | Thu 16 Jan 25 | |
Gabazine Hydrobromide REF: TR-G122495CAS: 104104-50-9 | - - - | 3,571.00 € | Tue 18 Feb 25 |
Ref: IN-DA008SG4
5mg | 174.00 € | ||
10mg | 168.00 € | ||
50mg | 342.00 € | ||
100mg | 546.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Gabazine
CAS:104104-50-9
Gabazine (SR95531) is an antagonist of GABAA receptors (Ki : 74-150 nM)
Formula:
C15H18BrN3O3
Purity:
98.51%
Color and Shape:
Solid
Molecular weight:
368.23
Ref: TM-T7622
5mg | 51.00 € | ||
10mg | 78.00 € | ||
25mg | 138.00 € | ||
50mg | 253.00 € | ||
100mg | 453.00 € | ||
200mg | 612.00 € | ||
1mL*10mM (DMSO) | 57.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
SR 95531 hydrobromide
CAS:104104-50-9
GABAA receptor antagonist that displaces [3H]-GABA in membranes of rat brain (Ki value 0.15 µM). …
Formula:
C15H17N3O3·HBr
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
368.23 g/mol
Ref: 3D-BS43265
10mg | 164.00 € | ||
50mg | 488.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Gabazine Hydrobromide
Controlled ProductCAS:104104-50-9
Formula:
C15H17N3O3·HBr
Color and Shape:
Neat
Molecular weight:
368.22
Ref: TR-G122495
500mg | 3,571.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025